KRAS and neoplasm: Together these findings suggest that partial-LOF and LOF mutants promote the development of different tumor types so that partial-LOF mutations should be more frequent in, for example, Burkitt lymphoma with chromosomal Myc-translocations than in Kras-driven PDAC.